Why should oxymetazoline (Afrin) and phenylephrine (Neosynephrine) be avoided in pediatric epistaxis?

• A. These medications should be avoided if a child cannot follow instructions to blow their nose, or are unable to tolerate the administration of nasal medication
• B. They are contraindicated in all children under 12
• C. They cause irreversible nasal mucosa damage
• D. They are ineffective in stopping epistaxis in children

Answer: (A)

Topical vasoconstrictors like oxymetazoline and phenylephrine work by shrinking nasal blood vessels to slow bleeding, but they carry systemic absorption risks, especially in young children. Their safety relies on correct, targeted administration and the child’s ability to cooperate—blowing the nose beforehand helps clear clots and ensures the spray reaches the nasal mucosa, while tolerating the spray prevents swallowing or misapplication. If a child cannot follow instructions to blow their nose or cannot tolerate nasal administration, the medication is more likely to be swallowed or misapplied, increasing the chance of systemic effects such as high blood pressure, rapid heart rate, or agitation. For pediatric epistaxis, safer first-line management emphasizes direct nasal pressure, nasal packing, or cautery under appropriate supervision, reserving vasoconstrictors for situations where proper technique and cooperation can be ensured.